Covid-19 Kardiyak Tutulumunda Manyetik Rezonans Görüntüleme
Referanslar
WHO Coronavirus (COVID-19) (15 Ekim 2023 tarihinde https://covid19.who.int adresinden ulaşılmıştır)
Zhang SF, Tuo JL, Huang XB, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018;13(1).
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.
Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281-92.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.
Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60.
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10.
Han Y, Chen T, Bryant J, et al. Society for cardiovascular magnetic resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson. 2020;22(1):26.
Rudski L, Januzzi JL, Rigolin VH, et al. Multimodality imaging in evaluation of cardiovascular complications in patients with COVID-19: JACC scientific expert panel. J Am Coll Cardiol. 2020;76(11):1345-57.
Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022;43(11):1059-103.
Ferreira VM, Plein S, Wong TC, et al. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson. 2023;25(1):21.
Bangalore S, Sharma A, Slotwiner A, et al. ST-segment elevation in patients with covid-19 - a case series. N Engl J Med. 2020;382(25):2478-80.
Sheth AR, Grewal US, Patel HP, et al. Possible mechanisms responsible for acute coronary events in COVID-19. Med Hypotheses. 2020;143:110125.
Burkert FR, Niederreiter L, Dichtl W, et al. Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis. Eur Heart J Case Rep. 2021;5(2).
Hu T. Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management. Front Pharmacol. 2022;13:965714.
Doyen D, Moceri P, Ducreux D, et al. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395(10235):1516.
Aeschlimann FA, Misra N, Hussein T, et al. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance-based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson. 2021;23(1):140.
Chakraborty A, Philip R, Santoso M, et al. Cardiovascular magnetic resonance in children with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: institutional protocol-based medium-term follow-up study. Pediatr Cardiol. 2022;43(8):1879-87.
Sperotto F, Friedman KG, Son MBF, et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-22.
Van Osch D, Asselbergs FW, Teske AJ. Takotsubo cardiomyopathy in COVID-19: a case report. Haemodynamic and therapeutic considerations. Eur Heart J Case Rep. 2020;4(FI1):1-6.
Moady G, Atar S. Stress-induced cardiomyopathy-considerations for diagnosis and management during the COVID-19 pandemic. Medicina. 2022;58(2):192.
Dong N, Cai J, Zhou Y, et al. End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV. JACC Heart Fail. 2020;8(6):515-7.
Rafiee MJ, Babaki Fard F, Friedrich MG. COVID-19, myocardial edema and dexamethasone. Med Hypotheses. 2020;145:110307.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8.
Teuwen LA, Geldhof V, Pasut A, et al. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389-91.
Sang CJ, Burkett A, Heindl B, et al. Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovasc Pathol. 2021;54:107370.
Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300.
Maiese A, Frati P, Del Duca F, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel). 2021;11(9):1647.
Jones EAV. Mechanism of COVID-19-induced cardiac damage from patient, in vitro and animal studies. Curr Heart Fail Rep. 2023;20(5):451-60.
Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation. 2021;143(10):1031-42.
Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2022;79(17):1717-56.
Seferovic PM, Tsutsui H, McNamara DM, et al. Heart failure association, heart failure society of America, and Japanese heart failure society position statement on endomyocardial biopsy. J Card Fail. 2021;27(7):727-43.
Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949-58.
Hanneman K, Houbois C, Schoffel A, et al. Combined cardiac fluorodeoxyglucose–positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19. JAMA Cardiol. 2022;7(3):298-308.
Rajiah PS, Kalisz K, Broncano J, et al. Myocardial strain evaluation with cardiovascular MRI: physics, principles, and clinical applications. Radiographics. 2022;42(4):968-90.
Petersen SE, Friedrich MG, Leiner T, et al. Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc Imaging. 2022;15(4):685-99.
Jenista ER, Wendell DC, Azevedo CF, et al. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice. J Cardiovasc Magn Reson. 2023;25(1):18.
Cummings KW, Bhalla S, Javidan-Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics. 2009;29(1):89-103.
Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461-74.
Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158-76.
Patel AR, Salerno M, Kwong RY, et al. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. J Am Coll Cardiol. 2021;78(16):1655-68.
Thornton GD, Shetye A, Knight DS, et al. Myocardial perfusion imaging after severe COVID-19 infection demonstrates regional ischemia rather than global blood flow reduction. Front Cardiovasc Med. 2021;8:764599.
Hillier E, Covone J, Friedrich MG. Oxygenation-sensitive cardiac MRI with vasoactive breathing maneuvers for the non-invasive assessment of coronary microvascular dysfunction. J Vis Exp. 2022;62(17):186.
Mathew RC, Bourque JM, Salerno M, et al. Cardiovascular imaging techniques to assess microvascular dysfunction. JACC Cardiovasc Imaging. 2020;13(7):1577-90.
Bratis K, Mahmoud I, Chiribiri A, et al. Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography. J Nucl Cardiol. 2013;20(5):860-63.
Sharrack N, Biglands JD, Plein S, et al. Quantitative Perfusion MRI – Techniques. (1). Academic Press; 2023.
Hsu LY, Rhoads KL, Holly JE, et al. Quantitative myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass MRI technique in humans. J Magn Reson Imaging. 2006;23(3):315-22.
Zorach B, Shaw PW, Bourque J, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. J Cardiovasc Magn Reson. 2018;20(1):14.
Hsu L-Y, Jacobs M, Benovoy M, et al. Diagnostic performance of fully automated pixel-wise quantitative myocardial perfusion imaging by cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2018;11(5):697-707.
Patriki D, Gresser E, Manka R, et al. Approximation of the incidence of myocarditis by systematic screening with cardiac magnetic resonance imaging. JACC Heart Fail. 2018;6(7):573-79.
Adeboye A, Alkhatib D, Butt A, et al. A review of the role of imaging modalities in the evaluation of viral myocarditis with a special focus on COVID-19-related myocarditis. Diagnostics (Basel). 2022;12(2):549.
Panchal A, Kyvernitakis A, Mikolich JR, et al. Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI. Int J Cardiovasc Imaging. 2021;37(5):1721-33.
Luetkens JA, Isaak A, Öztürk C, et al. Cardiac MRI in suspected acute COVID-19 myocarditis. Radiol Cardiothorac Imaging. 2021;3(2).
Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6(8):945-50.
Sanchez Tijmes F, Marschner CA, de Matos JFRG, et al. Imaging acute and chronic cardiac complications of COVID-19 and after COVID-19 vaccination. Radiographics. 2023;43:9.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-73.
Ammirati E, Lupi L, Palazzini M, et al. Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis. Circulation. 2022;145(15):1123-39.
Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330-9.
Roca-Fernandez A, Wamil M, Telford A, et al. Cardiac abnormalities in long COVID 1-year post-SARS-CoV-2 infection. Open Heart. 2023;10:1.
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-24.
Galea N, Marchitelli L, Pambianchi G, et al. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2021;23(1):68.
Artico J, Shiwani H, Moon JC, et al. Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation. 2023;147(5):364-74.
Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866-78.
Drakos S, Chatzantonis G, Bietenbeck M, et al. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. 2021;11(1):15667.
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res. 2021;117(14):2705-29.
Evans PC, Rainger GE, Mason JC, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020;116(14):2177-84.
Bois MC, Boire NA, Layman AJ, et al. COVID-19–associated nonocclusive fibrin microthrombi in the heart. Circulation. 2021;143(3):230-43.
Verma A, Ramayya T, Upadhyaya A, et al. Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve. Eur J Clin Invest. 2022;52:12.
Caldeira D, Pinto FJ. COVID-19 and myocardial infarction. Lancet. 2021;398(10315):1963-64.
Fanaroff AC, Garcia S, Giri J. Myocardial infarction during the COVID-19 pandemic. JAMA. 2021;326(19):1916-18.
Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021;326(19):1940-52.
Vidula MK, Rajewska-Tabor J, Cao JJ, et al. Myocardial injury on CMR in patients with COVID-19 and suspected cardiac involvement. JACC Cardiovasc Imaging. 2023;16(5):609-24.
Philip AM, George LJ, John KJ, et al. A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection. J Clin Transl Res. 2021;7(6):797-808.
Karikalan S, Sharma M, Chandna M, et al. Intracardiac thrombus in coronavirus disease-2019. Cureus. 2022;14:3.
Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75-84.
Lan Y, Liu W, Zhou Y. Right ventricular damage in COVID-19: association between myocardial injury and COVID-19. Front Cardiovasc Med. 2021;8:606318.
Li Y, Li H, Zhu S, et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2287-99.
McErlane J, McCall P, Willder J, et al. Right ventricular free wall longitudinal strain is independently associated with mortality in mechanically ventilated patients with COVID-19. Ann Intensive Care. 2022;12(1):104.
Willder JM, McCall P, Messow CM, et al. Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open. 2021;11:1.
Aquaro GD, Negri F, De Luca A, et al. Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance. Int J Cardiol. 2018;271:359-65.
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian E. Association between right ventricular dysfunction and mortality in COVID-19 patients: a systematic review and meta-analysis. Clin Cardiol. 2021;44(10):1360-70.
Shah RM, Shah M, Shah S,et al. Takotsubo syndrome and COVID-19: associations and implications. Curr Probl Cardiol. 2021;46(3):100763.
Jabri A, Kalra A, Kumar A, et al. Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3:7.
Ghadri J-R, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J. 2018;39(22):2047-62.
Singh T, Khan H, Gamble DT, et al. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145(13):1002-19.
Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50(2):399-408.
Daniels CJ, Rajpal S, Greenshields JT, et al. Big Ten COVID-19 Cardiac Registry Investigators. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078-87.
Juhasz V, Csulak E, Szabo L, et al. Retrospective study of COVID-19 experiences in elite multinational aquatic athletes. Sci Rep. 2023;13(1):13978.
Domenech-Ximenos B, Sanz-de la Garza M, Prat-Gonzalez S, et al. Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes. J Cardiovasc Magn Reson. 2020;22(1):62.
Bartoszek M, Małek ŁA, Barczuk-Fale Rcka M, et al. Cardiac magnetic resonance follow-up of children after pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with initial cardiac involvement. J Magn Reson Imaging. 2022;55(3):883-91.
Theocharis P, Wong J, Pushparajah K, et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging. 2021;22(8):896-903.
Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369.
Tacke CE, Kuipers IM, Groenink M, et al. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging. 2011;4(6):712-20.
Husby A, Køber L. COVID-19 mRNA vaccination and myocarditis or pericarditis. Lancet. 2022;399(10342):2168-9.
Naveed Z, Li J, Wilton J, et al. Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines. J Am Coll Cardiol. 2022;80:20.
Wong H-L, Hu M, Zhou CK, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022;399(10342):2191-9.
Ling RR, Ramanathan K, Tan FL, et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(7):679-88.
Patone M, Mei XW, Handunnetthi L, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146(10):743-54.
Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331-40.
Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19(2):75-7.
Jain SS, Steele JM, Fonseca B, et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021;148:5.
Chelala L, Jeudy J, Hossain R, et al. Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. AJR Am J Roentgenol. 2022;218(4):651-7.
Dionne A, Sperotto F, Chamberlain S, et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021;6(12):1446-50.
Patel YR, Shah NR, Lombardi K, et al. Follow-up cardiovascular magnetic resonance findings in patients with COVID-19 vaccination-associated acute myocarditis. JACC Cardiovasc Imaging. 2022;15(11):2007-10.
Zhang SF, Tuo JL, Huang XB, et al. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018;13(1).
Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270-3.
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020;181(2):271-80.
Walls AC, Park YJ, Tortorici MA, et al. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell. 2020;181:281-92.
Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-9.
Zheng YY, Ma YT, Zhang JY, et al. COVID-19 and the cardiovascular system. Nat Rev Cardiol. 2020;17(5):259-60.
Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020;5(7):802-10.
Han Y, Chen T, Bryant J, et al. Society for cardiovascular magnetic resonance (SCMR) guidance for the practice of cardiovascular magnetic resonance during the COVID-19 pandemic. J Cardiovasc Magn Reson. 2020;22(1):26.
Rudski L, Januzzi JL, Rigolin VH, et al. Multimodality imaging in evaluation of cardiovascular complications in patients with COVID-19: JACC scientific expert panel. J Am Coll Cardiol. 2020;76(11):1345-57.
Task Force for the management of COVID-19 of the European Society of Cardiology. ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Eur Heart J. 2022;43(11):1059-103.
Ferreira VM, Plein S, Wong TC, et al. Cardiovascular magnetic resonance for evaluation of cardiac involvement in COVID-19: recommendations by the Society for Cardiovascular Magnetic Resonance. J Cardiovasc Magn Reson. 2023;25(1):21.
Bangalore S, Sharma A, Slotwiner A, et al. ST-segment elevation in patients with covid-19 - a case series. N Engl J Med. 2020;382(25):2478-80.
Sheth AR, Grewal US, Patel HP, et al. Possible mechanisms responsible for acute coronary events in COVID-19. Med Hypotheses. 2020;143:110125.
Burkert FR, Niederreiter L, Dichtl W, et al. Case report of a COVID-19-associated myocardial infarction with no obstructive coronary arteries: the mystery of the phantom embolus or local endothelitis. Eur Heart J Case Rep. 2021;5(2).
Hu T. Editorial: Cytokine Release Syndrome in COVID-19: Mechanisms and Management. Front Pharmacol. 2022;13:965714.
Doyen D, Moceri P, Ducreux D, et al. Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes. Lancet. 2020;395(10235):1516.
Aeschlimann FA, Misra N, Hussein T, et al. Myocardial involvement in children with post-COVID multisystem inflammatory syndrome: a cardiovascular magnetic resonance-based multicenter international study-the CARDOVID registry. J Cardiovasc Magn Reson. 2021;23(1):140.
Chakraborty A, Philip R, Santoso M, et al. Cardiovascular magnetic resonance in children with multisystem inflammatory syndrome in children (MIS-C) associated with COVID-19: institutional protocol-based medium-term follow-up study. Pediatr Cardiol. 2022;43(8):1879-87.
Sperotto F, Friedman KG, Son MBF, et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr. 2021;180(2):307-22.
Van Osch D, Asselbergs FW, Teske AJ. Takotsubo cardiomyopathy in COVID-19: a case report. Haemodynamic and therapeutic considerations. Eur Heart J Case Rep. 2020;4(FI1):1-6.
Moady G, Atar S. Stress-induced cardiomyopathy-considerations for diagnosis and management during the COVID-19 pandemic. Medicina. 2022;58(2):192.
Dong N, Cai J, Zhou Y, et al. End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV. JACC Heart Fail. 2020;8(6):515-7.
Rafiee MJ, Babaki Fard F, Friedrich MG. COVID-19, myocardial edema and dexamethasone. Med Hypotheses. 2020;145:110307.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-8.
Teuwen LA, Geldhof V, Pasut A, et al. COVID-19: the vasculature unleashed. Nat Rev Immunol. 2020;20(7):389-91.
Sang CJ, Burkett A, Heindl B, et al. Cardiac pathology in COVID-19: a single center autopsy experience. Cardiovasc Pathol. 2021;54:107370.
Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021;50:107300.
Maiese A, Frati P, Del Duca F, et al. Myocardial pathology in COVID-19-associated cardiac injury: a systematic review. Diagnostics (Basel). 2021;11(9):1647.
Jones EAV. Mechanism of COVID-19-induced cardiac damage from patient, in vitro and animal studies. Curr Heart Fail Rep. 2023;20(5):451-60.
Pellegrini D, Kawakami R, Guagliumi G, et al. Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study. Circulation. 2021;143(10):1031-42.
Gluckman TJ, Bhave NM, Allen LA, et al. 2022 ACC expert consensus decision pathway on cardiovascular sequelae of COVID-19 in adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American college of cardiology solution set oversight committee. J Am Coll Cardiol. 2022;79(17):1717-56.
Seferovic PM, Tsutsui H, McNamara DM, et al. Heart failure association, heart failure society of America, and Japanese heart failure society position statement on endomyocardial biopsy. J Card Fail. 2021;27(7):727-43.
Dweck MR, Bularga A, Hahn RT, et al. Global evaluation of echocardiography in patients with COVID-19. Eur Heart J Cardiovasc Imaging. 2020;21(9):949-58.
Hanneman K, Houbois C, Schoffel A, et al. Combined cardiac fluorodeoxyglucose–positron emission tomography/magnetic resonance imaging assessment of myocardial injury in patients who recently recovered from COVID-19. JAMA Cardiol. 2022;7(3):298-308.
Rajiah PS, Kalisz K, Broncano J, et al. Myocardial strain evaluation with cardiovascular MRI: physics, principles, and clinical applications. Radiographics. 2022;42(4):968-90.
Petersen SE, Friedrich MG, Leiner T, et al. Cardiovascular magnetic resonance for patients with COVID-19. JACC Cardiovasc Imaging. 2022;15(4):685-99.
Jenista ER, Wendell DC, Azevedo CF, et al. Revisiting how we perform late gadolinium enhancement CMR: insights gleaned over 25 years of clinical practice. J Cardiovasc Magn Reson. 2023;25(1):18.
Cummings KW, Bhalla S, Javidan-Nejad C, et al. A pattern-based approach to assessment of delayed enhancement in nonischemic cardiomyopathy at MR imaging. Radiographics. 2009;29(1):89-103.
Mahrholdt H, Wagner A, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26(15):1461-74.
Ferreira VM, Schulz-Menger J, Holmvang G, et al. Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations. J Am Coll Cardiol. 2018;72(24):3158-76.
Patel AR, Salerno M, Kwong RY, et al. Stress cardiac magnetic resonance myocardial perfusion imaging: JACC review topic of the week. J Am Coll Cardiol. 2021;78(16):1655-68.
Thornton GD, Shetye A, Knight DS, et al. Myocardial perfusion imaging after severe COVID-19 infection demonstrates regional ischemia rather than global blood flow reduction. Front Cardiovasc Med. 2021;8:764599.
Hillier E, Covone J, Friedrich MG. Oxygenation-sensitive cardiac MRI with vasoactive breathing maneuvers for the non-invasive assessment of coronary microvascular dysfunction. J Vis Exp. 2022;62(17):186.
Mathew RC, Bourque JM, Salerno M, et al. Cardiovascular imaging techniques to assess microvascular dysfunction. JACC Cardiovasc Imaging. 2020;13(7):1577-90.
Bratis K, Mahmoud I, Chiribiri A, et al. Quantitative myocardial perfusion imaging by cardiovascular magnetic resonance and positron emission tomography. J Nucl Cardiol. 2013;20(5):860-63.
Sharrack N, Biglands JD, Plein S, et al. Quantitative Perfusion MRI – Techniques. (1). Academic Press; 2023.
Hsu LY, Rhoads KL, Holly JE, et al. Quantitative myocardial perfusion analysis with a dual-bolus contrast-enhanced first-pass MRI technique in humans. J Magn Reson Imaging. 2006;23(3):315-22.
Zorach B, Shaw PW, Bourque J, et al. Quantitative cardiovascular magnetic resonance perfusion imaging identifies reduced flow reserve in microvascular coronary artery disease. J Cardiovasc Magn Reson. 2018;20(1):14.
Hsu L-Y, Jacobs M, Benovoy M, et al. Diagnostic performance of fully automated pixel-wise quantitative myocardial perfusion imaging by cardiovascular magnetic resonance. JACC Cardiovasc Imaging. 2018;11(5):697-707.
Patriki D, Gresser E, Manka R, et al. Approximation of the incidence of myocarditis by systematic screening with cardiac magnetic resonance imaging. JACC Heart Fail. 2018;6(7):573-79.
Adeboye A, Alkhatib D, Butt A, et al. A review of the role of imaging modalities in the evaluation of viral myocarditis with a special focus on COVID-19-related myocarditis. Diagnostics (Basel). 2022;12(2):549.
Panchal A, Kyvernitakis A, Mikolich JR, et al. Contemporary use of cardiac imaging for COVID-19 patients: a three center experience defining a potential role for cardiac MRI. Int J Cardiovasc Imaging. 2021;37(5):1721-33.
Luetkens JA, Isaak A, Öztürk C, et al. Cardiac MRI in suspected acute COVID-19 myocarditis. Radiol Cardiothorac Imaging. 2021;3(2).
Starekova J, Bluemke DA, Bradham WS, et al. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6(8):945-50.
Sanchez Tijmes F, Marschner CA, de Matos JFRG, et al. Imaging acute and chronic cardiac complications of COVID-19 and after COVID-19 vaccination. Radiographics. 2023;43:9.
Puntmann VO, Carerj ML, Wieters I, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-73.
Ammirati E, Lupi L, Palazzini M, et al. Prevalence, characteristics, and outcomes of COVID-19–associated acute myocarditis. Circulation. 2022;145(15):1123-39.
Huang L, Zhao P, Tang D, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. JACC Cardiovasc Imaging. 2020;13(11):2330-9.
Roca-Fernandez A, Wamil M, Telford A, et al. Cardiac abnormalities in long COVID 1-year post-SARS-CoV-2 infection. Open Heart. 2023;10:1.
Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-24.
Galea N, Marchitelli L, Pambianchi G, et al. T2-mapping increase is the prevalent imaging biomarker of myocardial involvement in active COVID-19: a cardiovascular magnetic resonance study. J Cardiovasc Magn Reson. 2021;23(1):68.
Artico J, Shiwani H, Moon JC, et al. Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study. Circulation. 2023;147(5):364-74.
Kotecha T, Knight DS, Razvi Y, et al. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021;42(19):1866-78.
Drakos S, Chatzantonis G, Bietenbeck M, et al. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. 2021;11(1):15667.
Cenko E, Badimon L, Bugiardini R, et al. Cardiovascular disease and COVID-19: a consensus paper from the ESC Working Group on Coronary Pathophysiology & Microcirculation, ESC Working Group on Thrombosis and the Association for Acute CardioVascular Care (ACVC), in collaboration with the European Heart Rhythm Association (EHRA). Cardiovasc Res. 2021;117(14):2705-29.
Evans PC, Rainger GE, Mason JC, et al. Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC council of basic cardiovascular science. Cardiovasc Res. 2020;116(14):2177-84.
Bois MC, Boire NA, Layman AJ, et al. COVID-19–associated nonocclusive fibrin microthrombi in the heart. Circulation. 2021;143(3):230-43.
Verma A, Ramayya T, Upadhyaya A, et al. Post COVID-19 syndrome with impairment of flow-mediated epicardial vasodilation and flow reserve. Eur J Clin Invest. 2022;52:12.
Caldeira D, Pinto FJ. COVID-19 and myocardial infarction. Lancet. 2021;398(10315):1963-64.
Fanaroff AC, Garcia S, Giri J. Myocardial infarction during the COVID-19 pandemic. JAMA. 2021;326(19):1916-18.
Saad M, Kennedy KF, Imran H, et al. Association between COVID-19 diagnosis and in-hospital mortality in patients hospitalized with ST-segment elevation myocardial infarction. JAMA. 2021;326(19):1940-52.
Vidula MK, Rajewska-Tabor J, Cao JJ, et al. Myocardial injury on CMR in patients with COVID-19 and suspected cardiac involvement. JACC Cardiovasc Imaging. 2023;16(5):609-24.
Philip AM, George LJ, John KJ, et al. A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection. J Clin Transl Res. 2021;7(6):797-808.
Karikalan S, Sharma M, Chandna M, et al. Intracardiac thrombus in coronavirus disease-2019. Cureus. 2022;14:3.
Srichai MB, Junor C, Rodriguez LL, et al. Clinical, imaging, and pathological characteristics of left ventricular thrombus: A comparison of contrast-enhanced magnetic resonance imaging, transthoracic echocardiography, and transesophageal echocardiography with surgical or pathological validation. Am Heart J. 2006;152(1):75-84.
Lan Y, Liu W, Zhou Y. Right ventricular damage in COVID-19: association between myocardial injury and COVID-19. Front Cardiovasc Med. 2021;8:606318.
Li Y, Li H, Zhu S, et al. Prognostic value of right ventricular longitudinal strain in patients with COVID-19. JACC Cardiovasc Imaging. 2020;13(11):2287-99.
McErlane J, McCall P, Willder J, et al. Right ventricular free wall longitudinal strain is independently associated with mortality in mechanically ventilated patients with COVID-19. Ann Intensive Care. 2022;12(1):104.
Willder JM, McCall P, Messow CM, et al. Study protocol for COVID-RV: a multicentre prospective observational cohort study of right ventricular dysfunction in ventilated patients with COVID-19. BMJ Open. 2021;11:1.
Aquaro GD, Negri F, De Luca A, et al. Role of right ventricular involvement in acute myocarditis, assessed by cardiac magnetic resonance. Int J Cardiol. 2018;271:359-65.
Diaz-Arocutipa C, Saucedo-Chinchay J, Argulian E. Association between right ventricular dysfunction and mortality in COVID-19 patients: a systematic review and meta-analysis. Clin Cardiol. 2021;44(10):1360-70.
Shah RM, Shah M, Shah S,et al. Takotsubo syndrome and COVID-19: associations and implications. Curr Probl Cardiol. 2021;46(3):100763.
Jabri A, Kalra A, Kumar A, et al. Incidence of stress cardiomyopathy during the coronavirus disease 2019 pandemic. JAMA Netw Open. 2020;3:7.
Ghadri J-R, Wittstein IS, Prasad A, et al. International expert consensus document on Takotsubo syndrome (Part II): diagnostic workup, outcome, and management. Eur Heart J. 2018;39(22):2047-62.
Singh T, Khan H, Gamble DT, et al. Takotsubo syndrome: pathophysiology, emerging concepts, and clinical implications. Circulation. 2022;145(13):1002-19.
Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50(2):399-408.
Daniels CJ, Rajpal S, Greenshields JT, et al. Big Ten COVID-19 Cardiac Registry Investigators. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 infection: results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078-87.
Juhasz V, Csulak E, Szabo L, et al. Retrospective study of COVID-19 experiences in elite multinational aquatic athletes. Sci Rep. 2023;13(1):13978.
Domenech-Ximenos B, Sanz-de la Garza M, Prat-Gonzalez S, et al. Prevalence and pattern of cardiovascular magnetic resonance late gadolinium enhancement in highly trained endurance athletes. J Cardiovasc Magn Reson. 2020;22(1):62.
Bartoszek M, Małek ŁA, Barczuk-Fale Rcka M, et al. Cardiac magnetic resonance follow-up of children after pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 with initial cardiac involvement. J Magn Reson Imaging. 2022;55(3):883-91.
Theocharis P, Wong J, Pushparajah K, et al. Multimodality cardiac evaluation in children and young adults with multisystem inflammation associated with COVID-19. Eur Heart J Cardiovasc Imaging. 2021;22(8):896-903.
Riphagen S, Gomez X, Gonzalez-Martinez C, et al. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607-8.
Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study. BMJ. 2020;369.
Tacke CE, Kuipers IM, Groenink M, et al. Cardiac magnetic resonance imaging for noninvasive assessment of cardiovascular disease during the follow-up of patients with Kawasaki disease. Circ Cardiovasc Imaging. 2011;4(6):712-20.
Husby A, Køber L. COVID-19 mRNA vaccination and myocarditis or pericarditis. Lancet. 2022;399(10342):2168-9.
Naveed Z, Li J, Wilton J, et al. Comparative risk of myocarditis/pericarditis following second doses of BNT162b2 and mRNA-1273 coronavirus vaccines. J Am Coll Cardiol. 2022;80:20.
Wong H-L, Hu M, Zhou CK, et al. Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases. Lancet. 2022;399(10342):2191-9.
Ling RR, Ramanathan K, Tan FL, et al. Myopericarditis following COVID-19 vaccination and non-COVID-19 vaccination: a systematic review and meta-analysis. Lancet Respir Med. 2022;10(7):679-88.
Patone M, Mei XW, Handunnetthi L, et al. Risk of myocarditis after sequential doses of COVID-19 vaccine and SARS-CoV-2 infection by age and sex. Circulation. 2022;146(10):743-54.
Oster ME, Shay DK, Su JR, et al. Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021. JAMA. 2022;327(4):331-40.
Heymans S, Cooper LT. Myocarditis after COVID-19 mRNA vaccination: clinical observations and potential mechanisms. Nat Rev Cardiol. 2022;19(2):75-7.
Jain SS, Steele JM, Fonseca B, et al. COVID-19 vaccination-associated myocarditis in adolescents. Pediatrics. 2021;148:5.
Chelala L, Jeudy J, Hossain R, et al. Cardiac MRI findings of myocarditis after COVID-19 mRNA vaccination in adolescents. AJR Am J Roentgenol. 2022;218(4):651-7.
Dionne A, Sperotto F, Chamberlain S, et al. Association of myocarditis with BNT162b2 messenger RNA COVID-19 vaccine in a case series of children. JAMA Cardiol. 2021;6(12):1446-50.
Patel YR, Shah NR, Lombardi K, et al. Follow-up cardiovascular magnetic resonance findings in patients with COVID-19 vaccination-associated acute myocarditis. JACC Cardiovasc Imaging. 2022;15(11):2007-10.
Sayfalar
39-52
Gelecek
27 Ocak 2025
Telif Hakkı (c) 2025 Akademisyen Yayınevi Kitap DOI Portalı
